These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3756078)

  • 1. The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids.
    Kerr DJ; Wheldon TE; Kerr AM; Freshney RI; Kaye SB
    Br J Cancer; 1986 Sep; 54(3):423-9. PubMed ID: 3756078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro chemosensitivity testing using the multicellular tumor spheroid model.
    Kerr DJ; Wheldon TE; Kerr AM; Kaye SB
    Cancer Drug Deliv; 1987; 4(2):63-74. PubMed ID: 3427553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic drug penetration studies in multicellular tumour spheroids.
    Kerr DJ; Wheldon TE; Hydns S; Kaye SB
    Xenobiotica; 1988 Jun; 18(6):641-8. PubMed ID: 3166552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C; Vidgen D
    Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative intracellular uptake of adriamycin and 4'-deoxydoxorubicin by non-small cell lung tumor cells in culture and its relationship to cell survival.
    Kerr DJ; Kerr AM; Freshney RI; Kaye SB
    Biochem Pharmacol; 1986 Aug; 35(16):2817-23. PubMed ID: 3741470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systems.
    Kerr DJ; Wheldon TE; Russell JG; Maurer HR; Florence AT; Halbert GW; Freshney RI; Kaye SB
    Eur J Cancer Clin Oncol; 1987 Sep; 23(9):1315-22. PubMed ID: 3678325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.
    Kerr DJ; Rogerson A; Morrison GJ; Florence AT; Kaye SB
    Br J Cancer; 1988 Oct; 58(4):432-6. PubMed ID: 3207598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.
    West CM; Stratford IJ
    Cancer Chemother Pharmacol; 1987; 20(2):109-14. PubMed ID: 2822273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
    Rodriguez A; Alpen EL; Mendonca M; DeGuzman RJ
    Radiat Res; 1988 Jun; 114(3):515-27. PubMed ID: 3375440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the effects of anthracycline derivatives on a human adenocarcinoma cell line (LoVo) grown as a monolayer and as spheroids.
    Soranzo C; Ingrosso A
    Anticancer Res; 1988; 8(3):369-73. PubMed ID: 3389741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.
    Durand RE
    Cancer Res; 1981 Sep; 41(9 Pt 1):3495-8. PubMed ID: 7260912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to chemotherapy of EMT6 spheroids as measured by growth delay and cell survival.
    Twentyman PR
    Br J Cancer; 1980 Aug; 42(2):297-304. PubMed ID: 7426337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response to cytotoxic drugs of EMT6 cells treated either as intact or disaggregated spheroids.
    Kwok TT; Twentyman PR
    Br J Cancer; 1985 Feb; 51(2):211-8. PubMed ID: 3966978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of anticancer drugs on multicellular spheroid of 9L rat brain tumor].
    Kohno T; Matsutani M; Hoshino T; Takakura K
    No To Shinkei; 1985 Oct; 37(10):991-7. PubMed ID: 3865669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between reductive drug metabolism in tumour tissue of anthracyclines in microspherical form and anti-tumour activity.
    Willmott N; Cummings J; Marley E; Smyth JF
    Biochem Pharmacol; 1990 Mar; 39(6):1055-62. PubMed ID: 2322293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of DNA breakage in cytotoxicity of doxorubicin, 9-deoxydoxorubicin, and 4-demethyl-6-deoxydoxorubicin in murine leukemia P388 cells.
    Capranico G; De Isabella P; Penco S; Tinelli S; Zunino F
    Cancer Res; 1989 Apr; 49(8):2022-7. PubMed ID: 2702645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPLC and flow cytometric analyses of uptake of adriamycin and menogaril by monolayers and multicell spheroids.
    Bichay TJ; Adams EG; Inch WR; Adams WJ; Brewer JE; Bhuyan BK
    Sel Cancer Ther; 1990; 6(4):153-66. PubMed ID: 2151298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin: a possible indirect radiosensitizer of hypoxic tumor cells.
    Durand RE
    Radiology; 1976 Apr; 119(1):217-22. PubMed ID: 1257446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo.
    Kerr DJ; Smart HE
    In Vivo; 1991; 5(4):385-8. PubMed ID: 1810425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.